Overall rank by patents
#32,814
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Pitney Pharmaceuticals PTY Limited
USPTO PatentsView assignee record - 8 granted patents across 3 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
8
Total patents granted
3
CPC technology areas
14.9
Avg claims per patent
-86%
5-year filing velocity
The verdict
Pitney holds 8 US patents across 3 technology areas, rank #32,814 of 50,000 tracked assignees.
- #32,814
- of 50,000 US assignees by volume
- Top 89%
- by Innovation Score (22.6/100)
- 14.9
- avg claims per patent
- -86%
- filing velocity, last 5 yrs
Portfolio overview
Pitney Pharmaceuticals PTY Limited has been granted 8 US utility patents between 2016 and 2025, placing Pitney Pharmaceuticals PTY Limited at rank #32,814 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.9 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Pitney Pharmaceuticals PTY Limited is one of the more focused assignees in the PatentsView dataset. By volume, Pitney sits between Pilepro Gmbh (8 patents, rank #32,810) and Plastpro 2000, Inc. (8 patents, rank #32,818) - the closest US assignees by grant volume. The composite Innovation Score of 22.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 7 in the 2015–2019 window, a -86% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Pitney Pharmaceuticals PTY Limited's 14.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Pitney Pharmaceuticals PTY Limited against peers pursuing similar technology classes.
Who files at Pitney's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Pilepro
PILEPRO GMBH
8 patents
- Pillar
PILLAR TECHNOLOGIES, INC.
8 patents
- Pimco 2664
PIMCO 2664 LIMITED
8 patents
- PINK Thermosysteme
PINK GMBH THERMOSYSTEME
8 patents
- Planar Motor Inco…
PLANAR MOTOR INCORPORATED
8 patents
- Plant Sensory Sys…
PLANT SENSORY SYSTEMS, LLC
8 patents
- Plasma-therm NES
PLASMA-THERM NES LLC
8 patents
- Plastpro 2000
PLASTPRO 2000, INC.
8 patents
- Pitney Pharmaceut… ◀
PITNEY PHARMACEUTICALS PTY LIMITED
8 patents
What this shows Pitney holds 8 patents at rank #32,814, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Pitney
By rank, the assignees closest to #32,814 in granted patent volume.
- Pilepro Gmbh #32,810 · 8 patents
- Pillar Technologies, Inc. #32,811 · 8 patents
- Pimco 2664 Limited #32,812 · 8 patents
- PINK Gmbh Thermosysteme #32,813 · 8 patents
- Planar Motor Incorporated #32,815 · 8 patents
- Plant Sensory Systems, Llc #32,816 · 8 patents
- Plasma-therm NES Llc #32,817 · 8 patents
- Plastpro 2000, Inc. #32,818 · 8 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Pitney's primary technology class.
- The Regents Of The University Of California 1,387 in class
- Novartis Ag 1,071 in class
- Merck Sharp & Dohme Llc 889 in class
- Bristol-myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board Of Regents Of The University Of Texas System 744 in class
- Hoffmann-la Roche Inc. 722 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 721 in class
Pitney's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
23 Top 89% higher than 11% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 12.5% |
| 2017 | 2 | 25.0% |
| 2018 | 2 | 25.0% |
| 2019 | 2 | 25.0% |
| 2025 | 1 | 12.5% |
Which technologies does Pitney Pharmaceuticals PTY Limited patent most?
Top 3 of 3 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Pitney Pharmaceuticals PTY Limited hold?
Pitney Pharmaceuticals PTY Limited holds 8 US granted patents filed between 2016 and 2025, spanning 3 technology areas.
What is Pitney Pharmaceuticals PTY Limited's Innovation Score?
Pitney Pharmaceuticals PTY Limited has an Innovation Score of 22.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Pitney Pharmaceuticals PTY Limited focus on?
Pitney Pharmaceuticals PTY Limited's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 8 patents. The company has filed patents in 3 CPC subclasses total.
Is Pitney Pharmaceuticals PTY Limited's patent filing rate increasing or decreasing?
Pitney Pharmaceuticals PTY Limited's recent filing velocity is -86% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Pitney Pharmaceuticals PTY Limited's patents?
Pitney Pharmaceuticals PTY Limited's patents average 14.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Pitney Pharmaceuticals PTY Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Pitney's 8 grants land it in the top 89% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Pitney ranks #32,814 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.